Fig. 5From: Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient RegistryOverall survival and local control of patients with liver metastases volumes < 40 cm3 (a), (b) and ≥ 40 cm3 (c) and (d) by dose (≥ 100 BED vs. < 100 BED). Overall survival and local control are significantly better for tumors ≥ 40 cm3 treated with BED ≥ 100 compared to BED < 100 (panels C, (d)Back to article page